These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 2765448)

  • 1. Corneal thickness in nephropathic cystinosis.
    Katz B; Melles RB; Schneider JA; Rao NA
    Br J Ophthalmol; 1989 Aug; 73(8):665-8. PubMed ID: 2765448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spatial and temporal sequence of corneal crystal deposition in nephropathic cystinosis.
    Melles RB; Schneider JA; Rao NA; Katz B
    Am J Ophthalmol; 1987 Dec; 104(6):598-604. PubMed ID: 3688102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrast sensitivity function in nephropathic cystinosis.
    Katz B; Melles RB; Schneider JA
    Arch Ophthalmol; 1987 Dec; 105(12):1667-9. PubMed ID: 3689189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo confocal microscopy and anterior segment optical coherence tomography analysis of the cornea in nephropathic cystinosis.
    Labbé A; Niaudet P; Loirat C; Charbit M; Guest G; Baudouin C
    Ophthalmology; 2009 May; 116(5):870-6. PubMed ID: 19410944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corneal crystals in nephropathic cystinosis: natural history and treatment with cysteamine eyedrops.
    Gahl WA; Kuehl EM; Iwata F; Lindblad A; Kaiser-Kupfer MI
    Mol Genet Metab; 2000; 71(1-2):100-20. PubMed ID: 11001803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Examination of corneal deposits in nephropathic cystinosis using in vivo confocal microscopy and anterior segment optical coherence tomography: an age-dependent cross sectional study.
    Csorba A; Maka E; Maneschg OA; Szabó A; Szentmáry N; Csidey M; Resch M; Imre L; Knézy K; Nagy ZZ
    BMC Ophthalmol; 2020 Feb; 20(1):73. PubMed ID: 32102651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ocular changes in nephropathic cystinosis: The course of the gold-dust.
    Flockerzi E; Daas L; Schlötzer-Schrehardt U; Zimpfer A; Bohle R; Seitz B
    Int Ophthalmol; 2019 Jun; 39(6):1413-1418. PubMed ID: 29916124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Nephropathic and benign cystinosis (author's transl)].
    Thiel HJ; Voigt GJ; Dörner K; Hake H; von Denffer H
    Klin Monbl Augenheilkd; 1980 Sep; 177(3):324-35. PubMed ID: 7453068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glare disability in nephropathic cystinosis.
    Katz B; Melles RB; Schneider JA
    Arch Ophthalmol; 1987 Dec; 105(12):1670-1. PubMed ID: 3689190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nephropathic cystinosis in children: An overlooked disease.
    Soliman NA; El-Baroudy R; Rizk A; Bazaraa H; Younan A
    Saudi J Kidney Dis Transpl; 2009 May; 20(3):436-42. PubMed ID: 19414947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new gel formulation of topical cysteamine for the treatment of corneal cystine crystals in cystinosis: the Cystadrops OCT-1 study.
    Labbé A; Baudouin C; Deschênes G; Loirat C; Charbit M; Guest G; Niaudet P
    Mol Genet Metab; 2014 Mar; 111(3):314-320. PubMed ID: 24440466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cysteamine eyedrops for treatment of corneal cysteine deposits in infantile cystinosis].
    Gräf M; Grote A; Wagner F
    Klin Monbl Augenheilkd; 1992 Jul; 201(1):48-50. PubMed ID: 1513127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corneal sensitivity in nephropathic cystinosis.
    Katz B; Melles RB; Schneider JA
    Am J Ophthalmol; 1987 Oct; 104(4):413-6. PubMed ID: 3661652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corneal Manifestation in Patients with Infantile Nephropathic Cystinosis.
    Kruse F; Keidel LF; Priglinger S; Luft N; Priglinger C
    Klin Monbl Augenheilkd; 2023 Mar; 240(3):260-265. PubMed ID: 36696914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Photophobia and corneal crystal density in nephropathic cystinosis: an in vivo confocal microscopy and anterior-segment optical coherence tomography study.
    Liang H; Baudouin C; Tahiri Joutei Hassani R; Brignole-Baudouin F; Labbe A
    Invest Ophthalmol Vis Sci; 2015 May; 56(5):3218-25. PubMed ID: 26024106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late-onset nephropathic cystinosis: clinical presentation, outcome, and genotyping.
    Servais A; Morinière V; Grünfeld JP; Noël LH; Goujon JM; Chadefaux-Vekemans B; Antignac C
    Clin J Am Soc Nephrol; 2008 Jan; 3(1):27-35. PubMed ID: 18178779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of topical cysteamine in nephropathic cystinosis.
    Al-Hemidan A; Shoughy SS; Kozak I; Tabbara KF
    Br J Ophthalmol; 2017 Sep; 101(9):1234-1237. PubMed ID: 28057644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clearance of corneal crystals in nephropathic cystinosis by topical cysteamine 0.5%.
    Jones NP; Postlethwaite RJ; Noble JL
    Br J Ophthalmol; 1991 May; 75(5):311-2. PubMed ID: 2036352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ophthalmic manifestations and histopathology of infantile nephropathic cystinosis: report of a case and review of the literature.
    Tsilou E; Zhou M; Gahl W; Sieving PC; Chan CC
    Surv Ophthalmol; 2007; 52(1):97-105. PubMed ID: 17212992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-related prevalence of anterior segment complications in patients with infantile nephropathic cystinosis.
    Tsilou ET; Rubin BI; Reed GF; Iwata F; Gahl W; Kaiser-Kupfer MI
    Cornea; 2002 Mar; 21(2):173-6. PubMed ID: 11862089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.